This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

Uroplasty Inc. (UPI)

NASDAQ: Health Care

Get a 5-page Ratings Report on (UPI) now
$3.370.11 | 3.37%
04/17/14 - 4:00 PM ET
Company Profile
Price and Volume
Recent Price 3.26
52 Week High 5.40
52 Week Low 1.69
Avg. Daily Vol. (Mil) 0.11
Beta (3 year) -1.95
Share Related Items
Mkt Cap (Mil) 70.53
Shares Out (Mil) 21.64
Float (Mil) 17.70
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 5.70
Current Ratio 6.10
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 2.97
Price/Book 4.96
Price/Cash Flow -15.80
Per Share Data
Earnings -0.25
Sales 1.10
Book Value 0.66
Cash Flow -0.21
Business Summary
Uroplasty, Inc. is a medical device company that develops, manufactures and markets proprietary products for the treatment of voiding dysfunctions.
General Information
5420 Feltl Road
Minnetonka, MN 55343
www.uroplasty.com
Industry : Health Services
Sector: Health Care
Employees: 96
CEO: Mr. Robert E. Kill
Short Interest
Current Month (Mil) 0.11
Previous Month (Mil) 0.13
Short Interest Ratio (Days) 2.90
Management Effectiveness
Return on Equity n.a.
Return on Assets -29.80
Return on Investments -36.50
Profitability
Gross Margin 88.30
EBIT Margin -22.30
Profit Margin -21.80
(UPI) News

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
DOW 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 +2.54 0.14%
NASDAQ 4,095.5160 +9.2910 0.23%

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs